Downregulation of p-ERK1/2 and p-AKT expression by curcumin and tetrahydrocurcumin in hepatocellular carcinoma-induced tumors in nude mice

1. Sebolt-Leopold JS, Herrera R, Ohren JF. The mitogenactivated protein kinase pathway for moleculartargeted cancer treatment. Recent Results Cancer Res. 2007; 172:155-67.10.1007/978-3-540-31209-3_9Search in Google Scholar

2. Roskoski JR. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Critical Reviews in Oncology/Hematology. 2007; 62:179-213.10.1016/j.critrevonc.2007.01.006Search in Google Scholar

3. Jiang BH, Liu LZ. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res. 2009; 102:19-65.10.1016/S0065-230X(09)02002-8Open DOISearch in Google Scholar

4. Schmitz KJ, Wohlschlaeger J, Lang H, Sotiropoulos GC, Malago M, Steveling K, Reis H, Cicinnati VR, Schmid KW, Baba HA. Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol. 2008; 48:83-90.10.1016/j.jhep.2007.08.01817998146Search in Google Scholar

5. Yoysungnoen P, Wirachwong P, Changtam C, Suksamrarn A, Patumraj S. Suppression of tumor neocapillarization induced by HepG2 cells in nude mice supplemented with curcumin or tetrahydrocurcumin: An in vivo comparative study. Asian Biomed. 2008; 2:77-82.Search in Google Scholar

6. Yoysungnoen P, Wirachwong P, Changtam C, Suksamrarn A, Patumraj S. Anti-cancer and antiangiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J Gastroenterol. 2008; 14:2003-9.10.3748/wjg.14.2003270152018395899Open DOISearch in Google Scholar

7. Lee SL, Huang WJ, Lin WW, Lee SS, Chen CH. Preparation and anti-inflammatory activities of diarylheptanoid and diarylheptylamine analogs. Bioorg Med Chem. 2005; 13:6175-81.10.1016/j.bmc.2005.06.05816084726Open DOISearch in Google Scholar

8. Tsuboi Y, Ichida T, Sugitani S, Genda T, Inayoshi J, Takamura M, Matsuda Y, Nomoto MAoyagi Y. Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma. Liver Int. 2004; 24:432-6.10.1111/j.1478-3231.2004.0940.x15482339Open DOISearch in Google Scholar

9. Wiesenauer CA, Yip-Schneider MT, Wang Y, Schmidt CM. Multiple anticancer effects of blocking MEKERK signaling in hepatocellular carcinoma. J Am Coll Surg. 2004; 198:410-21.10.1016/j.jamcollsurg.2003.10.00414992744Search in Google Scholar

10. Jiang BH, Liu L-Z. PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochimica et al. Biophysica Acta (BBA) - Proteins & Proteomics. 2008; 1784:150-8.10.1016/j.bbapap.2007.09.00817964232Search in Google Scholar

11. Yoysungnoen P, Wirachwong P, Bhattarakosol P, Niimi H, Patumraj S. Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin Hemorheol Microcirc. 2006; 34:109-15.Search in Google Scholar

12. Namkoong S, Kim C-K, Cho Y-L, Kim J-H, Lee H, Ha K-S, Choe J, Kim P-H, Won M-H, Kwon Y-G, Shim EB, Kim Y-M. Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling. Cellular Signalling. 2009; 21:906-15.10.1016/j.cellsig.2009.01.03819385062Open DOISearch in Google Scholar

13. Agarwal S, Achari C, Praveen D, Roy KR, Reddy GV, Reddanna P. Inhibition of 12-LOX and COX-2 reduces the proliferation of human epidermoid carcinoma cells (A431) by modulating the ERK and PI3K-Akt signalling pathways. Exp Dermatol. 2009; 18:939-46.10.1111/j.1600-0625.2009.00874.xSearch in Google Scholar

14. Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM, Pirmohamed M, Gescher AJ, Steward WP. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004; 10:6847-54.10.1158/1078-0432.CCR-04-0744Open DOISearch in Google Scholar

15. Sugiyama Y, Kawakishi S, Osawa T. Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem Pharmacol. 1996; 52:519-25.10.1016/0006-2952(96)00302-4Open DOISearch in Google Scholar

16. Takaba K, Hirose M, Yoshida Y, Kimura J, Ito N, Shirai T. Effects of n-tritriacontane-16, 18-dione, curcumin, chlorophyllin, dihydroguaiaretic acid, tannic acid and phytic acid on the initiation stage in a rat multi-organ carcinogenesis model. Cancer Letters. 1997; 113:39-46.10.1016/S0304-3835(96)04579-XSearch in Google Scholar

17. Okada K, Wangpoengtrakul C, Tanaka T, Toyokuni S, Uchida K, Osawa T. Curcumin and especially tetrahydrocurcumin ameliorate oxidative stressinduced renal injury in mice. J Nutr. 2001; 131:2090-5.10.1093/jn/131.8.209011481399Search in Google Scholar